Printer Friendly
The Free Library
14,669,769 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Bausch & Lomb Responds to May 2 CDC Release of Preliminary Data on Fusarium Keratitis Cases.


ROCHESTER, N.Y. -- Bausch & Lomb made the following statement in response to preliminary data released late yesterday by the U.S. Centers for Disease Control and Prevention Centers for Disease Control and Prevention (CDC), agency of the U.S. Public Health Service since 1973, with headquarters in Atlanta; it was established in 1946 as the Communicable Disease Center.  as part of its investigation of Fusarium Fusarium

a genus of fungi; some species are plant pathogens and some are opportunistic infectious agents of humans and animals. Many also produce trichothecene toxins which cause poisoning of animals if the infected material, usually stored feed, is eaten.
 keratitis keratitis

Inflammation of the cornea (see eye). The conjunctiva may also be inflamed (keratoconjunctivitis). Depending on the cause, including dryness of the eye (from low tear production or inability to close the eye), chemical or physical injury, or certain
 cases.

These preliminary data require further examination and should be placed in proper context. Bausch & Lomb continues to fully cooperate with the U.S. Food and Drug Administration and the CDC See Control Data, century date change and Back Orifice.

CDC - Control Data Corporation
 in a comprehensive investigation to determine the root cause of the unusual incidence of fungal keratitis A fungal keratitis is an 'inflammation of the eye's cornea' (called keratitis) that results from infection by a fungal organism. Keratomycosis is the latin terminology equivalent of fungal keratitis - it is the fungal infection of the cornea, the anterior part of . Bausch & Lomb will review this information later today with the CDC in a previously scheduled meeting.

Studies suggest that Fusarium keratitis occurs among contact lens contact lens, thin plastic lens worn between the eye and eyelid that may be used instead of eyeglasses. Actors, models, and others wear them for appearance, and athletes use them for safety and convenience.  wearers at a low rate. It would be expected that the distribution of lens care products associated with these cases would be roughly proportional to the products' relative market share. In the small sample of cases CDC has analyzed to date, the 27-percent representation of ReNu(R) MultiPlus(R) solution is well below its approximate 40-percent market share. MultiPlus solution is used by nearly 11 million contact lens wearers in the U.S. in either its branded or private label form. More than 30 million consumers worldwide have used MultiPlus, which has maintained an excellent record of safety and effectiveness since it was introduced in 1997.

The 57-percent share of cases preliminarily reported for the company's MoistureLoc(R) formula is significantly and disproportionately higher than its U.S. market share of less than 10 percent, which represents approximately 2.3 million users. This disproportionate representation of the MoistureLoc formula in the CDC case reports is the reason Bausch & Lomb voluntarily withdrew MoistureLoc from the market while the investigation to determine the cause of these unusual infections continues.

Bausch & Lomb is the eye health company, dedicated to perfecting vision and enhancing life for consumers around the world. Its core businesses include soft and rigid gas permeable gas permeable gas adj (lenses) → luftdurchlässig  contact lenses and lens care products, and ophthalmic surgical and pharmaceutical products. The Bausch & Lomb name is one of the best known and most respected healthcare brands in the world. Founded in 1853, the Company is headquartered in Rochester, New York This article is about the city of Rochester in Monroe County. For the town in Ulster County, see Rochester, Ulster County, New York.
Rochester, once known as The Flour City, and more recently as The Flower City or
. Bausch & Lomb's 2004 revenues were $2.2 billion; it employs approximately 13,700 people worldwide and its products are available in more than 100 countries. More information about the Company can be found on the Bausch & Lomb Web site at www.bausch.com. Copyright Bausch & Lomb Incorporated.
COPYRIGHT 2006 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:May 3, 2006
Words:400
Previous Article:Preliminary Figures for Financial Year 2005/2006: Heidelberg Continues to Increase Earnings Power.
Next Article:Leading Global Technology and Systems Integration Partners Endorse New EIM Solutions From Business Objects; New Products, Services, and Partnerships...



Related Articles
Bausch & Lomb Collaborates with Experts to Investigate Extent and Cause of Fungal Eye Infections.(Company overview)
Bausch & Lomb Temporarily Suspends U.S. Shipments of ReNu(R) with MoistureLoc(R) Produced at Greenville, S.C., Manufacturing Facility Pending...
BRIEFCASE.(Business)
The Mason Law Firm Announces Class Action Lawsuit Against Bausch & Lomb; Lawsuit Filed on Behalf of Persons Who Used Defective Contact Lens Solution.
Bausch & Lomb Clarifies Reporting of Fusarium Keratitis Cases to FDA.
CDC Report Supports Bausch & Lomb's Decision to Recall MoistureLoc(R) Solution, Only Product Associated with Unusual Increase in Fusarium Infections.
Connecticut Corneal Transplant Patient Files Lawsuit Against Bausch & Lomb For Injuries In New York Court.
Bausch & Lomb Comments on Fusarium Keratitis Article.
Three new litigation groups join ATLA roster; another is revitalized.(Communications report)
Lawyers focus on lens solution lawsuits.

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles